Krystal Biotech, Inc.

KRYSNASDAQHealthcare● Active

$301.76

+$0.76(+0.25%)

Market Cap$8.9B

P/E Ratio—

52W High$319.48

52W Low$127.99

Avg Volume279K

Open$302.47

Beta0.53

Overview

Krystal Biotech, Inc. (KRYS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · KRYS · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

137

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Krystal Biotech, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

KRYS insider buying and selling by quarter

KRYS insider selling · KRYS insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

364K182K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · KRYS ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

KRYS executive sell shares · KRYS board member insider trading · KRYS insider trading SEC filing

Showing 70 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	320	$300.75	$96K	1,402,835	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	593	$302.25	$179K	1,402,242	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	247	$303.17	$75K	1,401,995	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	400	$304.89	$122K	1,401,595	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	480	$305.87	$147K	1,401,115	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	1,348	$307.09	$414K	1,399,767	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	12,729	$307.81	$3.92M⚡	1,387,038	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	3,803	$308.89	$1.17M⚡	1,383,235	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	2,801	$309.95	$868K	1,380,434	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	2,039	$310.94	$634K	1,378,395	Form 4
Jun 4, 2026	Krishnan Suma President, R&D · Director	Sale	240	$311.65	$75K	1,378,155	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	320	$300.75	$96K	1,474,933	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	640	$302.24	$193K	1,474,293	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	176	$303.17	$53K	1,474,117	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	544	$304.81	$166K	1,473,573	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	589	$306.33	$180K	1,472,984	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	11,461	$307.68	$3.53M⚡	1,461,523	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	4,830	$308.47	$1.49M⚡	1,456,693	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	2,784	$309.49	$862K	1,453,909	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	2,652	$310.43	$823K	1,451,257	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	964	$311.36	$300K	1,450,293	Form 4
Jun 4, 2026	Krishnan Krish S President and CEO · Director	Sale	40	$312.23	$12K	1,450,253	Form 4
May 26, 2026	Thomas John Charles EVP, General Counsel	Sale	642	$302.03	$194K	0	Form 4
Mar 4, 2026	Krishnan Suma President, R&D · Director	Sale	407	$257.32	$105K	1,427,748	Form 4
Mar 4, 2026	Krishnan Suma President, R&D · Director	Sale	589	$258.54	$152K	1,427,159	Form 4

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

320

Price

$300.75

Value

$96K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

593

Price

$302.25

Value

$179K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

247

Price

$303.17

Value

$75K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

400

Price

$304.89

Value

$122K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

480

Price

$305.87

Value

$147K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

1,348

Price

$307.09

Value

$414K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

12,729

Price

$307.81

Value

$3.92M ⚡

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

3,803

Price

$308.89

Value

$1.17M ⚡

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

2,801

Price

$309.95

Value

$868K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

2,039

Price

$310.94

Value

$634K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Jun 4

240

Price

$311.65

Value

$75K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

320

Price

$300.75

Value

$96K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

640

Price

$302.24

Value

$193K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

176

Price

$303.17

Value

$53K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

544

Price

$304.81

Value

$166K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

589

Price

$306.33

Value

$180K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

11,461

Price

$307.68

Value

$3.53M ⚡

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

4,830

Price

$308.47

Value

$1.49M ⚡

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

2,784

Price

$309.49

Value

$862K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

2,652

Price

$310.43

Value

$823K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

964

Price

$311.36

Value

$300K

View Form 4 on SEC.gov

Krishnan Krish S

President and CEO · Director

Sale

Date

Jun 4

Price

$312.23

Value

$12K

View Form 4 on SEC.gov

Thomas John Charles

EVP, General Counsel

Sale

Date

May 26

642

Price

$302.03

Value

$194K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Mar 4

407

Price

$257.32

Value

$105K

View Form 4 on SEC.gov

Krishnan Suma

President, R&D · Director

Sale

Date

Mar 4

589

Price

$258.54

Value

$152K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About KRYS insider trading

KRYS insider trades

Krystal Biotech, Inc. (KRYS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Krishnan Suma (President, R&D · Director), Krishnan Krish S (President and CEO · Director), ROMANO KATHRYN (CAO). Over the past 12 months, 5 insiders have filed transactions with the SEC. KRYS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Krystal Biotech, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

KRYS insider trading · 5 questions

The insiders of Krystal Biotech, Inc. (KRYS) include executives and directors such as Krishnan Suma (President, R&D · Director), Krishnan Krish S (President and CEO · Director), ROMANO KATHRYN (CAO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

KRYS board member insider tradingwho are KRYS insidersKRYS insider rosterKrystal Biotech, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026